Akari Therapeutics PLC (AKTX) vs BioCardia, Inc. (BCDA)
Akari Therapeutics PLC and BioCardia, Inc. are both Biotechnology companies. Akari Therapeutics PLC and BioCardia, Inc. are of similar size ($17.6M and $16.2M). Across the 11 metrics below, BioCardia, Inc. leads on 6 and Akari Therapeutics PLC on 5.
Valuation
Profitability
| Metric | AKTX | BCDA | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (140.09%) | (1,803.19%) | (57.72%) |
| Return on assets | (69.16%) | (214.47%) | (49.22%) |
| Return on invested capital | (167.93%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack